Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone plus coenzyme Q10 for oral lichen planus
IRCT20201127049502N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of triamcinolone and coenzyme q10 in oral lichen planus (OLP), sponsored by Shahid Beheshti University of Medical Sciences. Started Dec 2020; status: completed.
02
Drugs
triamcinolonecoenzyme q10
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on IRCT20201127049502N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201127049502N1.